The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

[1]  C. Pui,et al.  Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. , 2000, The New England journal of medicine.

[2]  J. Shuster,et al.  Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Raimondi,et al.  Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation. , 1999, Blood.

[4]  A. Look,et al.  Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group Study. , 1998, Leukemia & lymphoma.

[5]  Y. Ravindranath,et al.  Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  M. Rhee,et al.  Characterization of human cellular gamma-glutamyl hydrolase. , 1998, Molecular pharmacology.

[7]  A. Borkhardt,et al.  Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. , 1997, Blood.

[8]  J. Bertino,et al.  gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias. , 1997, Oncology research.

[9]  Pui,et al.  Childhood Acute Lymphoblastic Leukemia. , 1997, The oncologist.

[10]  M. Relling,et al.  Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity. , 1997, Molecular pharmacology.

[11]  J. Downing,et al.  TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Downing,et al.  Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study. , 1997, Blood.

[13]  H P Koeffler,et al.  TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. , 1996, Blood.

[14]  P. Marynen,et al.  The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. , 1996, Blood.

[15]  E. Macintyre,et al.  High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. , 1995, Blood.

[16]  S. Shurtleff,et al.  TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. , 1995, Leukemia.

[17]  P. Meltzer,et al.  Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. , 1995, Cancer research.

[18]  E. Soeda,et al.  Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. , 1995, Nucleic acids research.

[19]  C. Reynolds,et al.  Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. , 1995, Blood.

[20]  D. Le Paslier,et al.  The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. , 1995, Blood.

[21]  D C Ward,et al.  Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Rowley,et al.  Identification of cytogenetically undetected 12p13 translocations and associated deletions with fluorescence in situ hybridization , 1995, Genes, chromosomes & cancer.

[23]  R. Kucherlapati,et al.  Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. , 1994, Blood.

[24]  M. Relling,et al.  Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. , 1994, The Journal of clinical investigation.

[25]  R. Berger,et al.  t( 12;21): A new recurrent translocation in acute lymphoblastic leukemia , 1994, Genes, chromosomes & cancer.

[26]  A. Admon,et al.  Expression cloning of a human cDNA encoding folylpoly(gamma-glutamate) synthetase and determination of its primary structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Look,et al.  Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1992, Blood.

[28]  A. Look,et al.  Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. , 1992, Blood.

[29]  L. Frankel,et al.  Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  F. Behm,et al.  Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study , 1990 .

[31]  J. Shuster,et al.  Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: a pilot prognostic factor analysis. , 1990, Blood.

[32]  Jonathan J. Shuster,et al.  Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study , 1990 .

[33]  S. Raimondi,et al.  Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia , 1986 .

[34]  C. Pui,et al.  Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. , 1985, Blood.

[35]  A. Look,et al.  Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. , 1982, Blood.

[36]  S. Sallan,et al.  The childhood leukemias. , 1981, The Journal of pediatrics.

[37]  Mitchell J. Mergenthaler.  Nonparametrics: Statistical Methods Based on Ranks , 1979 .

[38]  V. Barnett,et al.  Applied Linear Statistical Models , 1975 .

[39]  J. Shuster,et al.  Accumulation of High Levels of Methotrexate Polyglutamates in Lymphoblasts From Children With Hyperdiploid ( > 50 chromosomes ) B-Lineage Acute Lymphoblastic Leukemia : A Pediatric Oncology Group Study , 2003 .

[40]  J. Downing,et al.  Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup , 1999, Leukemia.

[41]  A. Look,et al.  Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  N. Winick,et al.  Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  M. Relling,et al.  Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. , 1996, The Journal of clinical investigation.

[44]  C. Pui.  Medical progress : childhood leukemias , 1995 .

[45]  B. Schweitzer,et al.  Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia. , 1991, Leukemia research.

[46]  D. Rosenblatt,et al.  Methotrexate polyglutamate synthesis in lymphoblasts from children with acute lymphoblastic leukemia. , 1987, Developmental pharmacology and therapeutics.

[47]  D. Rosenblatt,et al.  Methotrexate metabolism by bone marrow cells from patients with leukemia. , 1983, Advances in experimental medicine and biology.

[48]  A. Witte,et al.  Synthesis of methotrexate polyglutamates by bone marrow cells from patients with leukemia and lymphoma. , 1980, Developmental pharmacology and therapeutics.

[49]  H. Toutenburg,et al.  Lehmann, E. L., Nonparametrics: Statistical Methods Based on Ranks, San Francisco. Holden‐Day, Inc., 1975. 480 S., $ 22.95 . , 1977 .